Month: February 2024

SEATTLE, Feb. 22, 2024 (GLOBE NEWSWIRE) — Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, announced today that it will present new preclinical data on KVA12123, the Company’s anti-VISTA antibody, in acute myeloid leukemia (AML) at the American Association for Cancer Research (AACR) Blood Cancer Discovery Symposium, to be held on March 4-6 in Boston, Massachusetts. Thierry Guillaudeux, Ph.D., Chief Scientific Officer of Kineta, will be presenting the poster. Presentation DetailsPoster Title: VISTA a potential new Immuno-oncology therapeutic target to treat human Acute Myeloid LeukemiaDate and Time:   Tuesday, March 5, 2024Time:   6:45 P.M.– 8:45 P.M. Eastern TimeLocation: Westin Copley Place P21 The abstract will...

The partnership offers Amerant advisors and HNW clients access to a broad private market menu along with iCapital’s technology and comprehensive solutions MIAMI, ZURICH & NEW YORK, Feb. 22, 2024 (GLOBE NEWSWIRE) — Amerant Investments, a wholly owned subsidiary of Amerant Bank – the largest community bank in Florida – announced today that it has entered into a strategic relationship with iCapital[1], the global fintech platform driving the world’s alternative investment marketplace for the wealth management industry. This collaboration will provide Amerant Investment’s financial advisors, along with their clients, access to private market opportunities and analytics. The partnership will also entail oversight of the entire investment and education experience through a unified technology platform and operating system....

CINCINNATI, Feb. 22, 2024 (GLOBE NEWSWIRE) — Workhorse Group Inc. (Nasdaq: WKHS) (“Workhorse” or “the Company”), an American technology company focused on pioneering the transition to zero-emission commercial vehicles, today announced it has added Riverview International Trucks (“Riverview”) as its latest vehicle dealer, bringing the Company’s total dealer count in California to five. With locations in West Sacramento and Redding, Riverview is a family owned and operated full-service heavy-duty truck dealership that has been serving Northern California since 1981. Riverview’s customer-first approach has allowed it to forge longstanding partnerships with leading businesses in California. Customers have relied on Riverview for over four decades to provide quality vehicles from leading OEMs as well as full-service lease, contract...

Company to Host Conference Call, February 29, 2024 at 4:30 p.m. ET SAN DIEGO, Feb. 22, 2024 (GLOBE NEWSWIRE) — Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment and prevention of rare diseases, will release its financial results for the fourth quarter and full year ended December 31, 2023, after the market close on Thursday, February 29, 2024. Management will then host a webcast and conference call at 4:30 p.m. ET on February 29.Title: Capricor Therapeutics Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Update Conference Call and Webcast   Date: Thursday, February 29, 2024   Time: 4:30 p.m. ET   Conference Call Details: Toll-Free: 1-888-886-7786International: 1-416-764-8658Conference ID: 83986877 Participants...

MINNEAPOLIS, Feb. 22, 2024 (GLOBE NEWSWIRE) — Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced its distribution partner, SeaStar Medical Holding Corporation (Nasdaq: ICU) (SeaStar Medical), has received Humanitarian Device Exemption (HDE) from the U.S. Food and Drug Administration (FDA) for Quelimmune™, its pediatric Selective Cytopheretic Device. Quelimmune provides a new therapy option for children weighing 10 kg or more who have acute kidney injury (AKI) and sepsis or a septic condition requiring continuous kidney replacement therapy (CKRT) in a hospital intensive care unit. Nuwellis has an exclusive U.S. license and distribution agreement with SeaStar Medical to distribute Quelimmune and will market and distribute the device to...